Skip to main content
MedCap logo

MedCap — Investor Relations & Filings

Ticker · MCAP ISIN · SE0009160872 LEI · 549300NGO5XAJ6TL8719 ST Financial and insurance activities
Open in API
Filings indexed 169 across all filing types
Latest filing 2026-05-20 Transaction in Own Shar…
Country SE Sweden
Listing ST MCAP

About MedCap

https://medcap.se/en/

MedCap is an investment company that acquires and develops profitable, market-leading niche companies within the life science sector. The group's strategy focuses on long-term ownership of small and medium-sized enterprises, primarily in Northern Europe, with potential for international growth. Operations are organized into three business areas: MedTech, Assistive Tech, and Specialty Pharma. MedCap supports its portfolio companies by providing capital, expertise, experience, and networks to foster their development and expansion.

Recent filings

Filing Released Lang Actions
Återköp av aktier i MedCap 15 maj 2026 - 20 maj 2026 – återköpsprogram avslutat
Transaction in Own Shares Classification · 95% confidence The document is a press release detailing MedCap AB’s completed share buyback program, including number of shares repurchased, transaction dates, and total values. This matches the definition of a Transaction in Own Shares (share repurchases).
2026-05-20 Swedish
Återköp av aktier i MedCap 7 maj 2026 – 13 maj 2026
Transaction in Own Shares Classification · 95% confidence The document is a press release detailing the company’s repurchase of its own shares (22,900 shares) under a board‐approved buyback program, including dates, volumes, prices, total transactions, and regulatory references (MAR, Safe Harbour regulation). This clearly matches the category for a transaction in own shares (share repurchase).
2026-05-13 Swedish
MedCap beslutar om aktieåterköpsprogram
Regulatory Filings
2026-05-06 English
Stämmokommuniké årsstämma 4 maj 2026
Regulatory Filings
2026-05-04 Swedish
Interim / Quarterly Report 2026
Interim / Quarterly Report Classification · 92% confidence The document is titled “Delårsrapport Januari–Mars 2026” (Swedish for Interim Report January–March 2026) and covers detailed first‐quarter financial results, including full income statement, segment breakdowns, management commentary (VD-ord), cash flow, balance sheet metrics, and forward‐looking discussion. It is substantive (over 46,000 characters) and clearly constitutes the company’s actual interim/quarterly financial report rather than a brief announcement or presentation. Therefore, it matches the definition of an Interim / Quarterly Report (IR). Q1 2026
2026-04-29 Swedish
Interim / Quarterly Report 2026
Interim / Quarterly Report Classification · 93% confidence The document is clearly a comprehensive interim financial report covering the first quarter (January–March 2026). It includes detailed financial statements, segment analysis, management commentary, performance metrics, and tables. It is not merely an announcement or presentation; it constitutes the actual quarterly report itself. Therefore it falls under the Interim / Quarterly Report category (Code: IR). Q1 2026
2026-04-29 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.